Hodgkin's lymphoma historical perspective: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Removing from Primary care) |
|||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{AS}}{{M.B}} | {{CMG}}; {{AE}} {{AS}}{{M.B}} | ||
==Overview== | ==Overview== | ||
Hodgkin's lymphoma was first | Hodgkin's lymphoma was first described by [[Thomas Hodgkin]], a British physician, in 1832. Since then, tremendous efforts of many scientifics have been continuing to provide more precise and comprehensive with [[pathology]], [[Cancer staging|staging]], and [[Treatment Planning|treatment]] of Hodgkin's lymphoma. | ||
==Historical Perspective== | ==Historical Perspective== | ||
* Hodgkin's lymphoma was first described by [[Thomas Hodgkin]], a British physician, in 1832.Although earliest description for this disease was provided by [[Marcello Malpighi]] in 1666.<ref name="Hoppe2007">{{cite book |author=Hellman S |editor=Hoppe RT, Mauch PT, Armitage JO, Diehl V, Weiss LM |title=Hodgkin Lymphoma |chapter=Brief Consideration of Thomas Hodgkin and His Times |publisher=Wolters Kluwer Health/Lippincott Williams & Wilkins |location=Philadelphia |year=2007 |edition=2nd |pages=3–6 |isbn=0-7817-6422-X |oclc= |doi= |accessdate=}}</ref><ref name="Hodgkin1832">{{cite journal |title=On some morbid experiences of the absorbent glands and spleen |author=Hodgkin T |journal=Med Chir Trans |volume=17 |pages=69–97 |year=1832}}</ref> | * Hodgkin's lymphoma was first described by [[Thomas Hodgkin]], a British physician, in 1832.Although earliest description for this disease was provided by [[Marcello Malpighi]] in 1666.<ref name="Hoppe2007">{{cite book |author=Hellman S |editor=Hoppe RT, Mauch PT, Armitage JO, Diehl V, Weiss LM |title=Hodgkin Lymphoma |chapter=Brief Consideration of Thomas Hodgkin and His Times |publisher=Wolters Kluwer Health/Lippincott Williams & Wilkins |location=Philadelphia |year=2007 |edition=2nd |pages=3–6 |isbn=0-7817-6422-X |oclc= |doi= |accessdate=}}</ref><ref name="Hodgkin1832">{{cite journal |title=On some morbid experiences of the absorbent glands and spleen |author=Hodgkin T |journal=Med Chir Trans |volume=17 |pages=69–97 |year=1832}}</ref> | ||
* Dr. Hodgkin's report of macroscopic | * Dr. Hodgkin's report of macroscopic description entitled "On some morbid appearances of the absorbent glands and spleen", was presented to the Medical and Chirurgical Society in London in 1832.<ref name="Hoppe2007" /> <ref name="Geller1984">{{cite journal | author = Geller SA | title = Comments on the anniversary of the description of Hodgkin's disease | journal = Journal of the National Medical Association | volume = 76 | issue = 8 | pages = 815–7 | date = August 1984 | pmid = 6381744 | pmc = 2609834 | doi = | url = }}</ref> | ||
* In 1856, [[Samuel Wilks]] independently reported on a series of patients with the same disease that Hodgkin had previously described.<ref name="Geller1984" /> Wilks, a successor to Hodgkin at Guy's Hospital, was unaware of Hodgkin's prior work on the subject. Bright made Wilks aware of Hodgkin's contribution and in 1865, Wilks published a second paper, entitled "Cases of enlargement of the lymphatic glands and spleen", in which he called the disease "Hodgkin's disease" in honor of his predecessor.<ref name="Geller1984" /> | * In 1856, [[Samuel Wilks]] independently reported on a series of patients with the same disease that Hodgkin had previously described.<ref name="Geller1984" /> Wilks, a successor to Hodgkin at Guy's Hospital, was unaware of Hodgkin's prior work on the subject. Bright made Wilks aware of Hodgkin's contribution and in 1865, Wilks published a second paper, entitled "Cases of enlargement of the lymphatic glands and spleen", in which he called the disease "Hodgkin's disease" in honor of his predecessor.<ref name="Geller1984" /> | ||
* Theodor Langhans and WS Greenfield first described the microscopic characteristics of Hodgkin's lymphoma in 1872 and 1878, respectively.<ref name="Hoppe2007" /> | * Theodor Langhans and WS Greenfield first described the [[microscopic]] characteristics of Hodgkin's lymphoma in 1872 and 1878, respectively.<ref name="Hoppe2007" /> | ||
* The cytogenetic characteristics of the malignant cells of Hodgkin's lymphoma which now is known as Reed–Sternberg cells, were described by Carl Sternberg, and Dorothy Reed in 1898 and 1902, respectively.<ref name="Hoppe2007" /><ref>{{Cite journal | * The [[Cytogenetics|cytogenetic]] characteristics of the [[Malignant|malignant cells]] of Hodgkin's lymphoma which now is known as Reed–Sternberg cells, were described by Carl Sternberg, and Dorothy Reed in 1898 and 1902, respectively.<ref name="Hoppe2007" /><ref>{{Cite journal | ||
| author = [[S. A. Pileri]], [[S. Ascani]], [[L. Leoncini]], [[E. Sabattini]], [[P. L. Zinzani]], [[P. P. Piccaluga]], [[A. Jr Pileri]], [[M. Giunti]], [[B. Falini]], [[G. B. Bolis]] & [[H. Stein]] | | author = [[S. A. Pileri]], [[S. Ascani]], [[L. Leoncini]], [[E. Sabattini]], [[P. L. Zinzani]], [[P. P. Piccaluga]], [[A. Jr Pileri]], [[M. Giunti]], [[B. Falini]], [[G. B. Bolis]] & [[H. Stein]] | ||
| title = Hodgkin's lymphoma: the pathologist's viewpoint | | title = Hodgkin's lymphoma: the pathologist's viewpoint | ||
| Line 21: | Line 21: | ||
| pmid = 11896065 | | pmid = 11896065 | ||
}}</ref> | }}</ref> | ||
In 1944, Jackson and Parker classified Hodgkin’s lymphoma into three subtypes: early Hodgkin's disease or paragranuloma, granuloma, and sarcoma. In 1956, Smetana and Cohen proposed a histopathological variant for granulomatous Hodgkin's disease, with sclerotic changes and better prognosis. <ref>{{Cite journal | * In 1944, Jackson and Parker classified Hodgkin’s lymphoma into three subtypes: early Hodgkin's disease or paragranuloma, granuloma, and sarcoma. In 1956, Smetana and Cohen proposed a [[Histopathology|histopathological]] variant for granulomatous Hodgkin's disease, with sclerotic changes and better prognosis. <ref>{{Cite journal | ||
| author = [[S. A. Pileri]], [[S. Ascani]], [[L. Leoncini]], [[E. Sabattini]], [[P. L. Zinzani]], [[P. P. Piccaluga]], [[A. Jr Pileri]], [[M. Giunti]], [[B. Falini]], [[G. B. Bolis]] & [[H. Stein]] | | author = [[S. A. Pileri]], [[S. Ascani]], [[L. Leoncini]], [[E. Sabattini]], [[P. L. Zinzani]], [[P. P. Piccaluga]], [[A. Jr Pileri]], [[M. Giunti]], [[B. Falini]], [[G. B. Bolis]] & [[H. Stein]] | ||
| title = Hodgkin's lymphoma: the pathologist's viewpoint | | title = Hodgkin's lymphoma: the pathologist's viewpoint | ||
| Line 32: | Line 32: | ||
| pmid = 11896065 | | pmid = 11896065 | ||
}}</ref> | }}</ref> | ||
In 1964 , Lukes, Butler, and Hicks termed this form as nodular sclerosis Hodgkin's disease. Their categorization system , simplified at the Rye conference in 1965 and has been used commonly from then on. <ref>{{Cite journal | * In 1964 , Lukes, Butler, and Hicks termed this form as nodular sclerosis Hodgkin's disease. Their categorization system, simplified at the Rye conference in 1965 and has been used commonly from then on. <ref>{{Cite journal | ||
| author = [[Z. Mechl]] & [[V. Kolar]] | | author = [[Z. Mechl]] & [[V. Kolar]] | ||
| title = [Chemotherapy of malignant melanoma] | | title = [Chemotherapy of malignant melanoma] | ||
| Line 43: | Line 43: | ||
| pmid = 1145344 | | pmid = 1145344 | ||
}}</ref> | }}</ref> | ||
In 1993 the International Lymphoma | * In 1993 the International Lymphoma Study Group (ILSG) in Berlin, provided a new lymphoma classification system and their consensus released as revised European–American lymphoma (REAL) classification In 1994, and subdivided Hodgkin’s lymphoma into two main types: [[Lymphocyte|lymphocyte predominant]] Hodgkin’s lymphoma and common Hodgkin’s lymphoma. <ref>{{Cite journal | ||
| author = [[N. L. Harris]], [[E. S. Jaffe]], [[H. Stein]], [[P. M. Banks]], [[J. K. Chan]], [[M. L. Cleary]], [[G. Delsol]], [[C. De Wolf-Peeters]], [[B. Falini]] & [[K. C. Gatter]] | | author = [[N. L. Harris]], [[E. S. Jaffe]], [[H. Stein]], [[P. M. Banks]], [[J. K. Chan]], [[M. L. Cleary]], [[G. Delsol]], [[C. De Wolf-Peeters]], [[B. Falini]] & [[K. C. Gatter]] | ||
| title = A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group | | title = A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group | ||
| Line 55: | Line 55: | ||
}}</ref> | }}</ref> | ||
Since 1997 The World Health Organisation (WHO) has been starting a project with committees of international hematopathologists and oncologists, who have developed lists and definitions of disease entities to ensure that the classification will be helpful to clinicians. They proposed their first approach in 2000 and after that, the relevant Clinical Advisory Committee (CAC) updates its latest revision every few years. <ref>{{Cite journal | * Since 1997 The [[World Health Organization|World Health Organisation]] ([[World Health Organization|WHO]]) has been starting a project with committees of international hematopathologists and oncologists, who have developed lists and definitions of disease entities to ensure that the classification will be helpful to clinicians. They proposed their first approach in 2000 and after that, the relevant Clinical Advisory Committee (CAC) updates its latest revision every few years. <ref>{{Cite journal | ||
| author = [[N. L. Harris]], [[E. S. Jaffe]], [[J. Diebold]], [[G. Flandrin]], [[H. K. Muller-Hermelink]], [[J. Vardiman]], [[T. A. Lister]] & [[C. D. Bloomfield]] | | author = [[N. L. Harris]], [[E. S. Jaffe]], [[J. Diebold]], [[G. Flandrin]], [[H. K. Muller-Hermelink]], [[J. Vardiman]], [[T. A. Lister]] & [[C. D. Bloomfield]] | ||
| title = The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 | | title = The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997 | ||
| Line 67: | Line 67: | ||
}}</ref> | }}</ref> | ||
* | * | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Latest revision as of 22:13, 29 July 2020
|
Hodgkin's lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hodgkin's lymphoma historical perspective On the Web |
|
American Roentgen Ray Society Images of Hodgkin's lymphoma historical perspective |
|
Risk calculators and risk factors for Hodgkin's lymphoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]Mohsen Basiri M.D.
Overview
Hodgkin's lymphoma was first described by Thomas Hodgkin, a British physician, in 1832. Since then, tremendous efforts of many scientifics have been continuing to provide more precise and comprehensive with pathology, staging, and treatment of Hodgkin's lymphoma.
Historical Perspective
- Hodgkin's lymphoma was first described by Thomas Hodgkin, a British physician, in 1832.Although earliest description for this disease was provided by Marcello Malpighi in 1666.[1][2]
- Dr. Hodgkin's report of macroscopic description entitled "On some morbid appearances of the absorbent glands and spleen", was presented to the Medical and Chirurgical Society in London in 1832.[1] [3]
- In 1856, Samuel Wilks independently reported on a series of patients with the same disease that Hodgkin had previously described.[3] Wilks, a successor to Hodgkin at Guy's Hospital, was unaware of Hodgkin's prior work on the subject. Bright made Wilks aware of Hodgkin's contribution and in 1865, Wilks published a second paper, entitled "Cases of enlargement of the lymphatic glands and spleen", in which he called the disease "Hodgkin's disease" in honor of his predecessor.[3]
- Theodor Langhans and WS Greenfield first described the microscopic characteristics of Hodgkin's lymphoma in 1872 and 1878, respectively.[1]
- The cytogenetic characteristics of the malignant cells of Hodgkin's lymphoma which now is known as Reed–Sternberg cells, were described by Carl Sternberg, and Dorothy Reed in 1898 and 1902, respectively.[1][4]
- In 1944, Jackson and Parker classified Hodgkin’s lymphoma into three subtypes: early Hodgkin's disease or paragranuloma, granuloma, and sarcoma. In 1956, Smetana and Cohen proposed a histopathological variant for granulomatous Hodgkin's disease, with sclerotic changes and better prognosis. [5]
- In 1964 , Lukes, Butler, and Hicks termed this form as nodular sclerosis Hodgkin's disease. Their categorization system, simplified at the Rye conference in 1965 and has been used commonly from then on. [6]
- In 1993 the International Lymphoma Study Group (ILSG) in Berlin, provided a new lymphoma classification system and their consensus released as revised European–American lymphoma (REAL) classification In 1994, and subdivided Hodgkin’s lymphoma into two main types: lymphocyte predominant Hodgkin’s lymphoma and common Hodgkin’s lymphoma. [7]
- Since 1997 The World Health Organisation (WHO) has been starting a project with committees of international hematopathologists and oncologists, who have developed lists and definitions of disease entities to ensure that the classification will be helpful to clinicians. They proposed their first approach in 2000 and after that, the relevant Clinical Advisory Committee (CAC) updates its latest revision every few years. [8]
References
- ↑ 1.0 1.1 1.2 1.3 Hellman S (2007). "Brief Consideration of Thomas Hodgkin and His Times". In Hoppe RT, Mauch PT, Armitage JO, Diehl V, Weiss LM. Hodgkin Lymphoma (2nd ed.). Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. pp. 3–6. ISBN 0-7817-6422-X.
- ↑ Hodgkin T (1832). "On some morbid experiences of the absorbent glands and spleen". Med Chir Trans. 17: 69–97.
- ↑ 3.0 3.1 3.2 Geller SA (August 1984). "Comments on the anniversary of the description of Hodgkin's disease". Journal of the National Medical Association. 76 (8): 815–7. PMC 2609834. PMID 6381744.
- ↑ S. A. Pileri, S. Ascani, L. Leoncini, E. Sabattini, P. L. Zinzani, P. P. Piccaluga, A. Jr Pileri, M. Giunti, B. Falini, G. B. Bolis & H. Stein (2002). "Hodgkin's lymphoma: the pathologist's viewpoint". Journal of clinical pathology. 55 (3): 162–176. PMID 11896065. Unknown parameter
|month=ignored (help) - ↑ S. A. Pileri, S. Ascani, L. Leoncini, E. Sabattini, P. L. Zinzani, P. P. Piccaluga, A. Jr Pileri, M. Giunti, B. Falini, G. B. Bolis & H. Stein (2002). "Hodgkin's lymphoma: the pathologist's viewpoint". Journal of clinical pathology. 55 (3): 162–176. PMID 11896065. Unknown parameter
|month=ignored (help) - ↑ Z. Mechl & V. Kolar (1975). "[Chemotherapy of malignant melanoma]". Rozhledy v chirurgii : mesicnik Ceskoslovenske chirurgicke spolecnosti. 54 (6): 405–407. PMID 1145344. Unknown parameter
|month=ignored (help) - ↑ N. L. Harris, E. S. Jaffe, H. Stein, P. M. Banks, J. K. Chan, M. L. Cleary, G. Delsol, C. De Wolf-Peeters, B. Falini & K. C. Gatter (1994). "A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group". Blood. 84 (5): 1361–1392. PMID 8068936. Unknown parameter
|month=ignored (help) - ↑ N. L. Harris, E. S. Jaffe, J. Diebold, G. Flandrin, H. K. Muller-Hermelink, J. Vardiman, T. A. Lister & C. D. Bloomfield (2000). "The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997". Histopathology. 36 (1): 69–86. PMID 10632755. Unknown parameter
|month=ignored (help)